Malignant Carcinoid Syndrome
"Malignant Carcinoid Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)
| Descriptor ID |
D008303
|
| MeSH Number(s) |
C04.557.465.625.650.200.500 C04.557.470.200.025.200.500 C04.557.580.625.650.200.500
|
| Concept/Terms |
Malignant Carcinoid Syndrome- Malignant Carcinoid Syndrome
- Carcinoid Syndrome, Malignant
- Carcinoid Syndromes, Malignant
- Malignant Carcinoid Syndromes
- Syndrome, Malignant Carcinoid
- Syndromes, Malignant Carcinoid
|
Below are MeSH descriptors whose meaning is more general than "Malignant Carcinoid Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Malignant Carcinoid Syndrome".
This graph shows the total number of publications written about "Malignant Carcinoid Syndrome" by people in this website by year, and whether "Malignant Carcinoid Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 1 | 2 |
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 4 | 0 | 4 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Malignant Carcinoid Syndrome" by people in Profiles.
-
Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration. Oncologist. 2023 07 05; 28(7):575-583.
-
Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis. Ann Surg Oncol. 2022 May; 29(5):3072-3084.
-
A Systematic?Review of Economic and Quality-of-Life Research in Carcinoid Syndrome. Pharmacoeconomics. 2021 11; 39(11):1271-1297.
-
Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index. Neuroendocrinology. 2021; 111(9):850-862.
-
Direct costs of carcinoid syndrome diarrhea among adults in the United States. World J Gastroenterol. 2019 Dec 21; 25(47):6857-6865.
-
Management of Diarrhea in Patients With Carcinoid Syndrome. Pancreas. 2019 09; 48(8):961-972.
-
Work productivity burden and indirect costs associated with carcinoid syndrome diarrhea. Expert Rev Pharmacoecon Outcomes Res. 2020 Oct; 20(5):507-511.
-
Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome. BMC Cancer. 2019 Mar 28; 19(1):274.
-
Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey study. Medicine (Baltimore). 2018 Nov; 97(47):e13390.
-
Carcinoid Syndrome and Costs of Care During the First Year After Diagnosis of Neuroendocrine Tumors Among Elderly Patients. Oncologist. 2017 12; 22(12):1451-1462.